Skip to content

Request a Sample

March 2020 MUTED-01

About EOS ^cu
Clinical Trials
EOS ^cu Industries
- Healthcare Environments
- Other Industries
EOS ^cu Partners
The Blog
What’s New
- News
- Events

About EOS ^cu
Clinical Trials
EOS ^cu Industries
- Healthcare Environments
- Other Industries
EOS ^cu Partners
The Blog
What’s New
- News
- Events

News

All
News
Hospitals
Infection Control
EOS in the Press
Patient Safety
Research
Copper
Events
International
Middle East
Trade Shows

News

< 1min read.

EOScu Covered In Healthcare Facilities Magazine | November 2015

Picture of EOScu Team

EOScu Team

11/13/15 3:39 PM

EOSCU was featured in the November 2015 edition of Healthcare Facilities Management Magazine. In...

Read more

*Testing demonstrates effective antibacterial activity against Staphylococcus aureus (ATCC 6538), Enterobacter aerogenes (ATCC 13048), Methicillin-resistant Staphylococcus aureus (MRSA-ATCC 33592), Escherichia coli O157:H7 (ATCC 35150) and Pseudomonas aeruginosa (ATCC 15442).

The use of EOS^cu is a supplement to, and not a substitute for, standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. EOS^cu has been shown to reduce microbial contamination but it does not necessarily prevent cross contamination. This product must not be waxed, painted, lacquered, varnished, or otherwise coated. This product must be installed by a certified EOS^cu fabricator only.

Antimicrobial EOS Surfaces^TMEPA Registration #89674-1

Contact Us
Site Map
Homepage

Copyright © 2024 EOS Surfaces

Terms of Use
Privacy Policy